Mapmyindia's share price hit the high of ₹1590 and a low of ₹1282.With the upper price band of the ipo at ₹1,008, the stock is likely to list at ₹1,353, indicating a premium of around 34.23% on the listing.
This is a jump from the ₹335 reported yesterday.Mapmyindia ipo gmp (grey market issue) was ruling at around the inr 1040 mark on thursday, according to market experts.The initial public offering (ipo) of bansal wire industries limited, a leading player in the steel wire industry, opened for bidding on 3rd july 2024 and will remain open till 5th.
The price range for the offer has been fixed at rs.As mapmyindia ipo gmp today is ₹ 1040, it means grey market is expecting mapmyindia ipo listing around ₹ 2073, which is more than double of its price band of ₹ 1000 to ₹ 1033 per equity share.
Emcure pharma ipo will list on bse, nse with tentative listing date fixed as wednesday.Initial public offer of 10,063,945 equity shares of ₹ 2 (aggregating upto ₹ 1,039.61), comprising a offer for sale of 10,063,945 eq shares of ₹ 2 (aggregating up to ₹1,039.61 cr) issue open date.Mapmyindia ipo subscription to start from dec 09 to dec 13, 2021.
The ipo opens on december 9, 2021, and closes on december 13, 2021.After three days of bidding from july 3rd to 5th, 2024, the public issue was subscribed 67.87 times, the retail portion of the book build issue was filled 7.
The company to raise ₹1,039.61 crores via ipo at a price band of ₹1000 to ₹1033.The ₹ 1039.61 cr ipo was subscribed a whopping 154.71 times on the third day of subscription on december 13.Select option from application number, pan number or demat account number.
The total ipo size is 1,039.61 crore, a fresh issue of 0 crores,.The nephro care ipo gmp is currently reported at ₹180.